Sommaire

• • ·Editorial Board

    Page :A6

    
• • ·Table of Contents

    Page :A7

    
• • ·Information for Readers

    Page :A31

    
• • ·JAAD Case Reports Article List

    Page :A33

    
• • ·Journal based CME Instructions and Information

    Page :A36

    

• Continuing Medical Education

  • ·Leprosy: Clinical aspects and diagnostic techniques

    Page :1-14

    Mayra B.C. Maymone, Melissa Laughter, Samantha Venkatesh, Mara M. Dacso, P. Narasimha Rao, Barbara M. Stryjewska, Jeremy Hugh, Robert P. Dellavalle, Cory A. Dunnick

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :15

    
  • ·Answers to CME examination

    Page :16

    
  • ·Leprosy: Treatment and management of complications

    Page :17-30

    Mayra B.C. Maymone, Samantha Venkatesh, Melissa Laughter, Rana Abdat, Jeremy Hugh, Mara M. Dacso, P. Narasimha Rao, Barbara M. Stryjewska, Cory A. Dunnick, Robert P. Dellavalle

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :31

    
  • ·Answers to CME examination

    Page :32

    

• Letter from the Editor

  • ·Dupilumab and cutaneous T-cell lymphoma

    Page :33-34

    Dirk M. Elston

    

• A Clinician's Perspective

  • ·Dupilumab cuts both ways

    Page :35-36

    Warren R. Heymann

    

• Commentary

  • ·Interleukin 4 and interleukin 13 inhibition: A promising therapeutic approach in bullous pemphigoid

    Page :37-38

    Shamir Geller

    

• Original Articles

  • ·Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo

    Page :39-45

    Andrea Chiricozzi, Martina Maurelli, Niccolò Gori, Giuseppe Argenziano, Clara De Simone, Giulia Calabrese, Giampiero Girolomoni, Ketty Peris

    Résumé Résumé Plan Plan  
  • ·Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series

    Page :46-52

    Rana Abdat, Reid A. Waldman, Valeria de Bedout, Annette Czernik, Michael Mcleod, Brett King, Samantha Gordon, Razzaque Ahmed, Anna Nichols, Marti Rothe, David Rosmarin

    Résumé Résumé Plan Plan  
  • ·Pathophysiologic mechanisms of itch in bullous pemphigoid

    Page :53-62

    Takashi Hashimoto, Christina Dorothy Kursewicz, Rachel Alison Fayne, Sonali Nanda, Serena Maya Shah, Leigh Nattkemper, Hiroo Yokozeki, Gil Yosipovitch

    Résumé Résumé Plan Plan  
  • ·Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways

    Page :63-70

    Michelle S. Min, Jianni Wu, Helen He, Juan Luis Sanz-Cabanillas, Ester Del Duca, Ning Zhang, Yael Renert-Yuval, Ana B. Pavel, Mark Lebwohl, Emma Guttman-Yassky

    Résumé Résumé Plan Plan  
  • ·Histologic comparison of tumor necrosis factor-? inhibitor–induced psoriasis and psoriasis vulgaris

    Page :71-77

    Jeffrey Zhu Hu, Steven D. Billings, Di Yan, Anthony Patrick Fernandez

    Résumé Résumé Plan Plan  
  • ·A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life

    Page :78-85

    Andrew Song, Ashley Gochoco, Tingting Zhan, Joya Sahu, Onder Alpdogan, Pierluigi Porcu, Neda Nikbakht, Wenyin Shi

    Résumé Résumé Plan Plan  
  • ·Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20-mg/mL hyaluronic acid filler in 4500 patients

    Page :86-95

    Shannon Humphrey, Derek H. Jones, Jean D. Carruthers, Alastair Carruthers, Katie Beleznay, Naissan Wesley, Jeanette M. Black, Sherri Vanderveen, Ardalan Minokadeh

    Résumé Résumé Plan Plan  
  • ·Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study

    Page :96-103

    Abby S. Van Voorhees, Linda Stein Gold, Mark Lebwohl, Bruce Strober, Charles Lynde, Stephen Tyring, Ashley Cauthen, Howard Sofen, Zuoshun Zhang, Maria Paris, Yao Wang

    Résumé Résumé Plan Plan  
  • ·Simplifying contraception requirements for iPLEDGE: A decision analysis

    Page :104-108

    John S. Barbieri, Andrea H. Roe, Arash Mostaghimi

    Résumé Résumé Plan Plan
  • ·Autologous cell–based therapy for male and female pattern hair loss using dermal sheath cup cells: A randomized placebo-controlled double-blinded dose-finding clinical study

    Page :109-116

    Ryoji Tsuboi, Shiro Niiyama, Ryokichi Irisawa, Kazutoshi Harada, Yosuke Nakazawa, Jiro Kishimoto

    Résumé Résumé Plan Plan  
  • ·Malignancy in dermatomyositis: A retrospective study of 201 patients seen at the University of Pennsylvania

    Page :117-122

    Kimberly Bowerman, David R. Pearson, Joyce Okawa, Victoria P. Werth

    Résumé Résumé Plan Plan  
  • ·The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata

    Page :123-130

    Nekma Meah, Dmitri Wall, Katherine York, Bevin Bhoyrul, Laita Bokhari, Daniel Asz Sigall, Wilma F. Bergfeld, Regina C. Betz, Ulrike Blume-Peytavi, Valerie Callender, Vijaya Chitreddy, Andrea Combalia, George Cotsarelis, Brittany Craiglow, Jeff Donovan, Samantha Eisman, Paul Farrant, Jack Green, Ramon Grimalt, Matthew Harries, Maria Hordinsky, Alan D. Irvine, Satoshi Itami, Victoria Jolliffe, Brett King, Won-Soo Lee, Amy McMichael, Andrew Messenger, Paradi Mirmirani, Elise Olsen, Seth J. Orlow, Bianca Maria Piraccini, Adriana Rakowska, Pascal Reygagne, Janet L. Roberts, Lidia Rudnicka, Jerry Shapiro, Pooja Sharma, Antonella Tosti, Annika Vogt, Martin Wade, Leona Yip, Abraham Zlotogorski, Rodney Sinclair

    Résumé Résumé Plan Plan  
  • ·PGAxBSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasis

    Page :131-138

    Linda Stein Gold, Jes B. Hansen, Dharm Patel, Karen A. Veverka, Bruce Strober

    Résumé Résumé Plan Plan  
  • ·Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry

    Page :139-150

    Esteban Daudén, Gregorio Carretero, Raquel Rivera, Carlos Ferrándiz, Mar Llamas-Velasco, Pablo de la Cueva, Isabel Belinchón, Francisco José Gómez-García, Enrique Herrera-Acosta, Diana Patricia Ruiz-Genao, Marta Ferrán-Farrés, Mercè Alsina, Ofelia Baniandrés-Rodríguez, José Luis Sánchez-Carazo, Antonio Sahuquillo-Torralba, Lourdes Rodriguez Fernández-Freire, Jaime Vilar-Alejo, Carmen García-Donoso, José Manuel Carrascosa, Enrique Herrera-Ceballos, José Luis López-Estebaranz, Rafael Botella-Estrada, Eva Segovia-Muñoz, Miguel Angel Descalzo, Ignacio García-Doval, the BIOBADADERM Study Group, Esteban Daudén, Mar Llamas-Velasco, Gregorio Carretero, Jaime Vilar-Alejo, Raquel Rivera, Carmen García-Donoso, Carlos Ferrándiz, José Manuel Carrascosa, Ferrán Ballescá, Pablo de la Cueva, Isabel Belinchón, Fran J. Gómez-García, Rafael Jiménez, Enrique Herrera-Ceballos, Enrique Herrera-Acosta, José Luis López-Estebaranz, Diana Patricia Ruiz-Genao, Marta Ferrán Farrés, Mercè Alsina, Ofelia Baniandrés, Lula Nieto, José Luis Sánchez-Carazo, Antonio Sahuquillo-Torralba, Rafael Botella-Estrada, Conrad Pujol Marco, Lourdes Rodríguez Fernández-Freire, Almudena Mateu Puchades, Ángeles Flórez Menéndez, Laura Salgado, Beatriz González Sixto, Noemí Eiris, Ignacio García-Doval, Miguel Ángel Descalzo Gallego, Marina de Vega Martínez

    Résumé Résumé Plan Plan  
  • ·Treatment of erythrodermic psoriasis with biologics: A systematic review

    Page :151-158

    Osward Y. Carrasquillo, Gabriela Pabón-Cartagena, Leyre A. Falto-Aizpurua, Marely Santiago-Vázquez, Karina J. Cancel-Artau, Gabriel Arias-Berrios, Rafael F. Martín-García

    Résumé Résumé Plan Plan  

• Dermatologic Surgery

  • ·Buffered lidocaine 1%/epinephrine 1:100,000 with sodium bicarbonate (sodium hydrogen carbonate) in a 3:1 ratio is less painful than a 9:1 ratio: A double-blind, randomized, placebo-controlled, crossover trial

    Page :159-165

    Alexandra Vent, Christian Surber, Nicole Tracy Graf Johansen, Verena Figueiredo, Georg Schönbächler, Laurence Imhof, Caroline Buset, Jürg Hafner

    Résumé Résumé Plan Plan  

• Commentary

  • ·Buffered lidocaine: The standard of care for cutaneous procedures

    Page :166-167

    Murad Alam, Brandon Worley

    
  • ·Teledermatology in the wake of COVID-19: Advantages and challenges to continued care in a time of disarray

    Page :168-169

    Rohit Gupta, Marina K. Ibraheim, Hung Q. Doan

    
  • ·Applying the ethical principles of resource allocation to drugs in limited supply during a public health crisis

    Page :170-171

    Ha Eun Kong, Jane M. Grant-Kels, Benjamin K. Stoff

    

• Dermatopathology

  • ·Comparison of C3d immunohistochemical staining to enzyme-linked immunosorbent assay and immunofluorescence for diagnosis of bullous pemphigoid

    Page :172-178

    Leo L. Wang, Ata S. Moshiri, Roberto Novoa, Cory L. Simpson, Junko Takeshita, Aimee S. Payne, Emily Y. Chu

    Résumé Résumé Plan Plan  

• Reviews

  • ·A review of the clinical indications, general principles and techniques related to compounding

    Page :179-183

    Elliott H. Campbell, Dirk M. Elston, Chad L. Straughan

    Résumé Résumé Plan Plan
  • ·Regulations, liability, safety, and economics related to compounding

    Page :184-188

    Elliott H. Campbell, Dirk M. Elston, Chad L. Straughan, Diana D. Antonovich

    Résumé Résumé Plan Plan
  • ·Review of talimogene laherparepvec: A first-in-class oncolytic viral treatment of advanced melanoma

    Page :189-196

    Karyn Haitz, Hasan Khosravi, Jennifer Y. Lin, Tyler Menge, Vinod E. Nambudiri

    Résumé Résumé Plan Plan  

• Research Letters

  • ·Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients

    Page :197-199

    Maria L. Espinosa, Morgan T. Nguyen, Amaia Saenz Aguirre, Maria Estela Martinez-Escala, Jane Kim, Christina J. Walker, David S. Pontes, Jonathan I. Silverberg, Jaehyuk Choi, Barbara Pro, Laura B. Pincus, Joan Guitart, Xiaolong A. Zhou

    
  • ·Hidradenitis suppurativa management using tumor necrosis factor inhibitors in patients younger than 18 years: A series of 12 cases

    Page :199-201

    Anne-Claire Fougerousse, Ziad Reguiai, Aude Roussel, Pierre-André Bécherel, Groupe d'Etudes Multicentriques (GEM) ResoVerneuil

    
  • ·The most cited articles and authors in dermatology: A bibliometric analysis of 1974-2019

    Page :201-205

    Mayra B.C. Maymone, Melissa Laughter, Neelam A. Vashi, John D. Jones, Jeremy Hugh, Cory A. Dunnick, Robert P. Dellavalle

    
  • ·Comorbidities in patients with lichen planopilaris: A retrospective case-control study

    Page :205-208

    Athena Manatis-Lornell, Jean-Phillip Okhovat, Dustin H. Marks, Dina Hagigeorges, Maryanne M. Senna

    
  • ·Alternating intralesional purified protein derivative and Candida antigen versus either agent alone in the treatment of multiple common warts

    Page :208-210

    Ahmad Nofal, Esraa Yehia, Elsayed Khater, Hagar Bessar

     
  • ·Time-series analysis of National Residency Matching Program data for the dermatology match in the United States

    Page :210-213

    Preetha Kamath, Lulu Wong, Scott Stratman, Caroline Halverstam

    
  • ·Capillary malformation with segmental distribution and central atrophy: A series of 7 cases

    Page :213-214

    Marta Ivars, Jose Manuel Azaña, Lisa Weibel, Martin Theiler, Pablo Boixeda, Diana Islas Norris, Victor Martinez-Glez, Noelia Agra, Lara Rodríguez-Laguna, Isabel Colmenero, María José Beato-Merino, Juan Carlos López-Gutiérrez

     
  • ·An increasing trend in the number of publications and research projects among dermatology residency applicants

    Page :214-216

    Maureen Ezekor, Adrian Pona, Abigail Cline, William W. Huang, Steven R. Feldman

     
  • ·Support group utilization and impact for patients with hidradenitis suppurativa

    Page :216-219

    Melissa Butt, Christian Cotton, Joslyn S. Kirby

    
  • ·Cutaneous disease in solid organ transplant recipients: A 5-year experience from a multidisciplinary medical-surgical transplant dermatology center

    Page :219-221

    Rina Allawh, Melissa Hoffman, Kumar S. Nadhan, Mark Abdelmalek, Carrie Ann Cusack, Alden M. Doyle, Christina Lee Chung

     
  • ·Apremilast and psoriasis in the real world: A retrospective case series

    Page :221-222

    Lauren Dozier, Gregory Bartos, Francisco Kerdel

    
  • ·S-100B serum protein is elevated in children with medium-to-giant congenital melanocytic nevi: An exploratory case-control study

    Page :222-224

    Alejandra Tomás-Velázquez, Juan Carlos López-Gutiérrez, Carmen Ceballos, Jorge M. Núñez-Córdoba, Pedro Redondo

     
  • ·Survival and demographic differences of periocular and nonperiocular sebaceous carcinomas

    Page :224-227

    Walter Liszewski, Gabriel Amon, Derek Blanchette, Ian A. Maher

    
  • ·Modeling of usage and estimation of cost for efinaconazole 10% topical solution in the treatment of onychomycosis

    Page :227-228

    Krysta Lin, Shari R. Lipner

    
  • ·When the treatment is the culprit: Prevalence of allergens in prescription topical steroids and immunomodulators

    Page :228-230

    Jennifer M. Tran, Margo J. Reeder

    
  • ·Treatments and associated outcomes of acral lentiginous melanoma: A review

    Page :230-234

    Marissa B. Lobl, Chelsea Santos, Dillon Clarey, Shauna Higgins, Edibaldo Silva-Lopez, Adam Sutton, Ashley Wysong

     
  • ·Improved survival for skin-primary presentation of adult T-cell leukemia/lymphoma (ATLL)

    Page :234-237

    Meera Jain, Kavita Goyal, Daniel O'Leary, Nathan Rubin, Kimberly Bohjanen, Amrita Goyal

     
  • ·Combining teledermatology with nonphysician members of the health care team to address access and compliance barriers in pediatric atopic dermatitis: A needs assessment

    Page :237-239

    Arianne S. Kourosh, Lynda Schneider, Elena B. Hawryluk, Lana X. Tong, Corinna J. Rea, Joseph Kvedar

     
  • ·Diagnostic testing for onychomycosis: A retrospective study over 17 years

    Page :239-241

    Solomon Geizhals, Victoria Cooley, Shari R. Lipner

     
  • ·How to eliminate scabies parasites from fomites: A high-throughput ex vivo experimental study

    Page :241-245

    Charlotte Bernigaud, Deepani D. Fernando, Hieng Lu, Sara Taylor, Gunter Hartel, Olivier Chosidow, Katja Fischer

    Résumé Résumé  
  • ·Skin pain and psoriasis

    Page :245-246

    Laurent Misery, Jason Shourick, Charles Taieb

     
  • ·Conversion to positive latent tuberculosis infection status is low in patients with hidradenitis suppurativa taking biologic medications

    Page :246-248

    Ariana Ellis, Urmi Khanna, AbdulAziz Galadari, Anthony P. Fernandez

    
  • ·Evaluation of adalimumab biosimilar in treatment of psoriatic arthritis with concomitant moderate to severe chronic plaque psoriasis: An open-labeled, prospective, pilot case series

    Page :248-251

    Sujay Khandpur, Prateek Sondhi, Neha Taneja, Preeti Sharma, Dayasagar Das, Alpana Sharma, Vishnubatla Sreenivas

    
  • ·Prevalence and predictors of pruritus in pemphigus compared with bullous pemphigoid: A cross-sectional study

    Page :251-254

    Robin Rolader, Lauren N. Daugherty, Yuan Liu, Ron J. Feldman

    
  • ·Adequacy of conservative 2- to 3-mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: Retrospective case series at a tertiary academic institution

    Page :254-255

    Teo Soleymani, Susan M. Swetter, S. Tyler Hollmig, Sumaira Z. Aasi

    
  • ·Real-world trends in biologic, oral systemic, and phototherapy in US patients with psoriasis or psoriatic arthritis

    Page :256-257

    Partik Singh, Jonathan I. Silverberg

     
  • ·Paternal acitretin exposure and the risk of miscarriage and major congenital malformations: A nationwide register-based cohort study

    Page :257-259

    Mia Noergaard, Stine Soendersted Clausen, Jon Trærup Andersen

     
  • ·Polycystic ovary syndrome in patients with hair thinning

    Page :260-261

    Sonya Prasad, Brianna De Souza, Laura J. Burns, Margaret Lippincott, Maryanne M. Senna

    
  • ·Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab

    Page :261-263

    Saxon D. Smith, Curdin Conrad, Michael Ramharter, Alice Benedix Gottlieb, Himanshu Patel, Wen Xu, Elisabeth Riedl, Christopher Schuster

    
  • ·Cyclosporine for treatment of acute generalized exanthematous pustulosis: A retrospective analysis

    Page :263-265

    Daniel Yanes, Emily Nguyen, Sotonye Imadojemu, Daniela Kroshinsky

    
  • ·Clinical and histopathologic features differentiating acute generalized exanthematous pustulosis and pustular psoriasis: A retrospective series

    Page :265-267

    James Isom, Diana S. Braswell, Alan Siroy, Jena Auerbach, Kiran Motaparthi

     
  • ·Long-term use of home narrowband ultraviolet B phototherapy demonstrates high patient satisfaction, compliance, and low rates of adverse effects: A survey study

    Page :267-269

    Michael O. Nguyen, Alice J. Watson, Cara Joyce, Elizabeth A. Buzney

    
  • ·Dermoscopic predictors to discriminate between in situ and early invasive lentigo maligna melanoma: A retrospective observational study

    Page :269-271

    Leonardo Peruilh-Bagolini, Zoe Apalla, Ruben González-Cuevas, Konstantinos Lallas, Chryssoula Papageorgiou, Mattheos Bobos, Sofia Magdalini Manoli, Theodosia Gkentsidi, Ioannis Spyridis, Elizabeth Lazaridou, Elena Sotiriou, Efstratios Vakirlis, Dimitrios Ioannides, Aimilios Lallas

     
  • ·The risk of myocardial infarction, stroke, and revascularization among patients with psoriasis treated with apremilast compared with biologics and disease-modifying antirheumatic drugs: A cohort study in the US MarketScan database

    Page :271-274

    Rebecca Persson, Katrina Wilcox Hagberg, Yiran Qian, Catherine Vasilakis-Scaramozza, Susan Jick

    
  • ·Factors associated with surgical site infection of the lower extremity: A retrospective cohort study

    Page :274-276

    Neera R. Nathan, Daniel M. O'Connor, Jeffrey B. Tiger, Laura M. Sowerby, Suzanne M. Olbricht, Su Luo

     
  • ·Spironolactone for treatment of female pattern hair loss

    Page :276-278

    Laura J. Burns, Brianna De Souza, Elizabeth Flynn, Dina Hagigeorges, Maryanne M. Senna

     
  • ·Viral reactivation in hospitalized patients with drug reaction with eosinophilia and systemic symptoms: A retrospective study from a tertiary medical center in the United States

    Page :278-279

    Nima Milani-Nejad, John Trinidad, Benjamin H. Kaffenberger

    
  • ·Back to the basics: Diluted bleach for COVID-19

    Page :279-280

    Parth Patel, Sanjna Sanghvi, Kunal Malik, Amor Khachemoune

    
  • ·Varicella-like exanthem as a specific COVID-19–associated skin manifestation: Multicenter case series of 22 patients

    Page :280-285

    Angelo Valerio Marzano, Giovanni Genovese, Gabriella Fabbrocini, Paolo Pigatto, Giuseppe Monfrecola, Bianca Maria Piraccini, Stefano Veraldi, Pietro Rubegni, Marco Cusini, Valentina Caputo, Franco Rongioletti, Emilio Berti, Piergiacomo Calzavara-Pinton

     
  • ·Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment

    Page :285-287

    Paolo Gisondi, Gianluigi Zaza, Micol Del Giglio, Mattia Rossi, Valentina Iacono, Giampiero Girolomoni

    
  • ·Recommendations for phototherapy during the COVID-19 pandemic

    Page :287-288

    Henry W. Lim, Steven R. Feldman, Abby S. Van Voorhees, Joel M. Gelfand

    
  • ·Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic

    Page :288-292

    Daniela P. Sanchez, Robert S. Kirsner, Hadar Lev-Tov

     
  • ·COVID-19 and biologics for psoriasis: A high-epidemic area experience—Bergamo, Lombardy, Italy

    Page :292-294

    Andrea Carugno, Daniele Mario Gambini, Francesca Raponi, Pamela Vezzoli, Andrea Gustavo C. Locatelli, Marco Di Mercurio, Elisa Robustelli Test, Paolo Sena

    

• Current Issues and Opinion

  • ·Perspectives on the recommendations for skin cancer management during the COVID-19 pandemic

    Page :295-296

    Larisa J. Geskin, Megan H. Trager, Sumaira Z. Aasi, David R. Bickers, Richard D. Carvajal, Paul Nghiem, Bret Taback, Nathalie C. Zeitouni, Faramarz H. Samie

    
  • ·Struggling with COVID: Every cancer patient is unique and needs their own plan

    Page :297-298

    Murad Alam

    

• Health Policy & Practice

  • ·Clinical effectiveness and cost-effectiveness of teledermatology: Where are we now, and what are the barriers to adoption?

    Page :299-307

    Robin H. Wang, John S. Barbieri, Harrison P. Nguyen, Robert Stavert, Howard P. Forman, Jean L. Bolognia, Carrie L. Kovarik, Group for Research of Policy Dynamics in Dermatology

    Résumé Résumé Plan Plan  

• Infographics

  • ·Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated

    Page :308-309

    Carlos Gustavo Wambier, Andy Goren

    Résumé Résumé  

• Beyond JAAD

  • ·Beyond JAAD July 2020: Articles of interest to dermatologists from the nondermatologic literature

    Page :310-313

    Andrew Bronin, Robert Phelps, Robert Sidbury

    Plan Plan

• JAAD Online

  • ·Screening nailfold capillaroscopy using a jeweler's loupe

    Page :e1

    Leena T. Ramani, Sally Pullman-Mooar, Michele Meltzer

    Plan Plan  
  • ·Diode laser for the treatment of lingual venous malformations

    Page :e3

    Melissa J. Danesh, Aria Vazirnia, Richard R. Anderson

    Plan Plan
  • ·A simple modification of a syringe barrel as an adapter for dermoscopic guided biopsy

    Page :e5

    Sandip Agrawal, Rachita Dhurat, Sanober Daruwalla, Aseem Sharma

    Plan Plan  
  • ·Sticky boundary to retain a thick layer of eutectic mixture of local anesthetics cream at surgical site for effective anesthesia

    Page :e7

    Ravi Shankar Jangra, Sanjeev Gupta, Somesh Gupta

    Plan Plan  
  • ·Starch-iodine test viewed through a dermoscope

    Page :e11

    Ishmeet Kaur, Deepak Jakhar

    Plan Plan  
  • ·Comment on: “Innovative protective covering over finger nail surgery dressing”

    Page :e13

    Charlotte Jaloux, Alice Mayoly, Florent Amatore, Aurélie Morand

     
  • ·Innovative fingernail surgery dressing

    Page :e15

    Sanjeev Gupta, Archana Singal, Ravi Shankar Jangra, Rohit Singla

    
  • ·Drug reaction with eosinophilia and systemic symptoms within 1 week of exposure to the drug

    Page :e17

    Sarita Sasidharanpillai, Kidangazhiathmana Ajithkumar, Anza Khader, Olasseri K. Reena Mariyath

    
  • ·Malignancy ratio and number needed to biopsy: Quality measures

    Page :e19

    Robert S. Kirsner, George W. Elgart, Daniel G. Federman

    
  • ·Dermatomyositis: Clinical features and pathogenesis

    Page :e21

    Karl M. Saardi, Cameron M. Zachary, Christine A. DeWitt, Michael A. Cardis

     
  • ·Reply to: “Comment on ‘Dermatomyositis—Clinical features and pathogenesis’”

    Page :e23

    Madeline E. DeWane, Reid Waldman, Jun Lu

    
  • ·Evidenced-based guidelines for tuberculosis screening before biologic treatment initiation

    Page :e25

    Payal Shah, Gabriel Rebick, Shirin Bajaj, Ludovic Desvignes, Kristen Lo Sicco

    
  • ·Reply to: “Evidence-based guidelines for tuberculosis screening before biologic treatment initiation”

    Page :e27

    Anthony P. Fernandez, Ariana Ellis, Urmi Khanna, AbdulAziz Galadari

    
  • ·Recommendations on dermatologic surgery during the COVID-19 pandemic

    Page :e29

    Samuel Antranig Der Sarkissian, Leo Kim, Michael Veness, Eleni Yiasemides, Deshan Frank Sebaratnam

    
  • ·Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations

    Page :e31

    Alecia Blaszczak, John C.L. Trinidad, Alexander M. Cartron

    
  • ·Does hydroxychloroquine combat COVID-19? A timeline of evidence

    Page :e33

    Erisa Alia, Jane M. Grant-Kels

    
  • ·COVID-19 and racial disparities

    Page :e35

    Monica Shah, Muskaan Sachdeva, Roni P. Dodiuk-Gad

    
  • ·Overzealous hand hygiene during the COVID 19 pandemic causing an increased incidence of hand eczema among general population

    Page :e37

    Mehak Singh, Manoj Pawar, Atul Bothra, Nishant Choudhary

    
  • ·Teledermatology in the era of COVID-19: Experience of an academic department of dermatology

    Page :e43

    Sara Perkins, Jeffrey M. Cohen, Caroline A. Nelson, Christopher G. Bunick

     
  • ·Personal protective equipment recommendations based on COVID-19 route of transmission

    Page :e45

    Mohit Kumar Gupta, Shari R. Lipner

     
  • ·Reply to: “Personal protective equipment recommendations based on COVID-19 route of transmission”

    Page :e47

    Gregory Cavanagh, Carlos Gustavo Wambier

    
  • ·Comment on “Dermatology residents and the care of COVID-19 patients”

    Page :e49

    Basil Patel

    
  • ·Invited response to the comment on “Dermatology residents and the care of COVID-19 patients”

    Page :e51

    Jane M. Grant-Kels

    
  • ·Proposed approach for reusing surgical masks in COVID-19 pandemic

    Page :e53

    Yuangang Liu, Sancy A. Leachman, Anna Bar

    Résumé Résumé  
  • ·What matters most: Why the COVID-19 pandemic should prompt us to revisit the dermatology resident selection process

    Page :e55

    Daniel Karasik, Daniel M. O'Connor, Neera R. Nathan

    
  • ·Cutaneous manifestations in COVID-19: Lessons learned from current evidence

    Page :e57

    Poonkiat Suchonwanit, Kanchana Leerunyakul, Chaninan Kositkuljorn

    
  • ·Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak

    Page :e61

    Diego Fernandez-Nieto, Juan Jimenez-Cauhe, Ana Suarez-Valle, Oscar M. Moreno-Arrones, David Saceda-Corralo, Arantxa Arana-Raja, Daniel Ortega-Quijano

     
  • ·Reply: Potential role of Janus kinase inhibitors in COVID-19

    Page :e65

    Maddalena Napolitano, Gabriella Fabbrocini, Cataldo Patruno

    
  • ·Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19

    Page :e67

    Danielle Peterson, William Damsky, Brett King

    
  • ·Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic

    Page :e69

    John Trinidad, Daniela Kroshinsky, Benjamin H. Kaffenberger, Nathan W. Rojek

     
  • ·Risks of hydroxychloroquine use for COVID-19 prophylaxis

    Page :e73

    Muskaan Sachdeva, Monica Shah, Michael Ziv, Eyal Leshem, Roni P. Dodiuk-Gad

    
  • ·Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis”

    Page :e75

    Jane M. Grant-Kels

    
  • ·Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment

    Page :e77

    Maria Vastarella, Angela Patrì, Maria Carmela Annunziata, Mariateresa Cantelli, Paola Nappa, Marco Tasso, Luisa Costa, Francesco Caso, Gabriella Fabbrocini

    
  • ·Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic

    Page :e81

    Monica Shah, Haley B. Naik, Raed Alhusayen

    
  • ·The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations

    Page :e83

    Sepideh Ashrafzadeh, Vinod E. Nambudiri

    
  • ·Invited commentary on the letter “The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations”

    Page :e85

    Carrie Kovarik, Ivy Lee, Trilokraj Tejasvi, Jules B. Lipoff

    
  • ·Reply to “Varicella-like exanthem as a specific COVID-19–associated skin manifestation: multicenter case series of 22 patients”: Discussing specificity

    Page :e87

    Daniel Ortega-Quijano, Juan Jimenez-Cauhe, Patricia Burgos-Blasco, Natalia Jimenez-Gomez, Diego Fernandez-Nieto

    
  • ·In memoriam: Haines Ely, MD, FAAD

    Page :e89

    Neal Bhatia

    
  • ·In memoriam: Oliverio Welsh-Lozano

    Page :e91

    Jorge Ocampo-Candiani, Minerva Gómez-Flores

     
  • ·Dermatology made easy, first edition

    Page :e93

    Nicholas Van Rooij

    
  • ·July iotaderma (#317)

    Page :e95

    Robert I. Rudolph

    
  • ·June iotaderma (#316)

    Page :e95

    Robert I. Rudolph